- Home
- ARRY vs BBOT Comparison
ARRY vs BBOT Comparison
Compare ARRY & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARRY | BBOT |
|---|---|---|
| Founded | 1989 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 548.3M | 442.6M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ARRY | BBOT |
|---|---|---|
| Price | $5.18 | $2.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 12 |
| Target Price | $6.95 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 11.0M | 601.8K |
| Earning Date | 11-04-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.56 | ★ 99.93 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,284,141,000.00 | N/A |
| Revenue This Year | $9.06 | N/A |
| Revenue Next Year | $14.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.22 | N/A |
| 52 Week Low | $3.09 | $1.98 |
| 52 Week High | $12.23 | $14.87 |
Technical Indicators
Market Signals| Indicator | ARRY | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 61.84 | 39.12 |
| Support Level | $4.54 | N/A |
| Resistance Level | $8.30 | $2.95 |
| Average True Range (ATR) | 0.46 | 0.22 |
| MACD | 0.19 | 0.09 |
| Stochastic Oscillator | 71.80 | 54.78 |
Price Performance
Historical ComparisonAbout ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.